Gemini Therapeutics
Latest round
- Series A
Last raised
- Oct 2017
Total raised
- $45M
Investors
- 3
About Gemini Therapeutics
Gemini Therapeutics, Inc.Founded in 2015, Gemini Therapeutics, Inc. operates out of Cambridge, US, specializing in therapies for eye diseases. The company recently underwent a merger with FS Development Corp. in a deal that enabled it to further enhance its clinical and preclinical portfolio. Jason Meyenburg serves as the CEO, leading the firm after its merger, which involved considerable investments from various esteemed investment groups, including Foresite Capital and Acorn Bioventures.Gemini Therapeutics, Inc. develops gene therapies aimed at treating debilitating eye diseases. The company’s primary focus is on innovative treatment options that leverage genetic engineering to address specific conditions affecting vision and eye health.Gemini Therapeutics, Inc.Following its merger on February 5, 2021, Gemini Therapeutics, Inc. The company aims to launch new gene therapy products targeting various ocular conditions in the next few years, enhancing its presence in the biotechnology market. Additionally, Gemini is exploring opportunities for geographic expansion into international markets, with plans to establish a foothold in Europe and Asia by 2024, capitalizing on the global demand for innovative eye treatments.
Who invested in Gemini Therapeutics
3 investors across 2 rounds
See all investors in Gemini Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gemini Therapeutics
Who invested in Gemini Therapeutics?
Gemini Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gemini Therapeutics raised?
Gemini Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gemini Therapeutics last raise money?
Gemini Therapeutics's most recent round on record is a Series A, in Oct 2017.
What does Gemini Therapeutics do?
Gemini Therapeutics is a biotechnology company.
Where is Gemini Therapeutics headquartered?
Gemini Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Gemini Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gemini Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gemini Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.